These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22009484)

  • 21. Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.
    Noblitt LW; Bangari DS; Shukla S; Knapp DW; Mohammed S; Kinch MS; Mittal SK
    Cancer Gene Ther; 2004 Nov; 11(11):757-66. PubMed ID: 15359289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury.
    Kim A; Seong KM; Choi YY; Shim S; Park S; Lee SS
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33265912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.
    Hong HN; Won YJ; Shim JH; Kim HJ; Han SH; Kim BS; Kim HS
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1649-1663. PubMed ID: 29948146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EPHA2/EFNA1 expression in human gastric cancer.
    Nakamura R; Kataoka H; Sato N; Kanamori M; Ihara M; Igarashi H; Ravshanov S; Wang YJ; Li ZY; Shimamura T; Kobayashi T; Konno H; Shinmura K; Tanaka M; Sugimura H
    Cancer Sci; 2005 Jan; 96(1):42-7. PubMed ID: 15649254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling.
    Shin JM; Han MS; Park JH; Lee SH; Kim TH; Lee SH
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.
    Tawadros T; Brown MD; Hart CA; Clarke NW
    Br J Cancer; 2012 Nov; 107(10):1737-44. PubMed ID: 23037715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.
    Li X; Wang L; Gu JW; Li B; Liu WP; Wang YG; Zhang X; Zhen HN; Fei Z
    Tumour Biol; 2010 Oct; 31(5):477-88. PubMed ID: 20571968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expressions of angiogenesis-related factors: CD105, EphA2 and EphrinA1 in laryngeal squamous cell carcinoma and clinical implication].
    Su J; Ji XB; Xie JH; Li W
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Dec; 51(12):929-936. PubMed ID: 27978884
    [No Abstract]   [Full Text] [Related]  

  • 29. VE-cadherin fusion protein substrate enhanced the vasculogenic mimicry capability of hepatocellular carcinoma cells.
    Shuai Q; Cao L; Qin Z; Zhang Y; Gu Z; Yang J
    J Mater Chem B; 2020 Feb; 8(8):1699-1712. PubMed ID: 32016269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
    Wykosky J; Debinski W
    Mol Cancer Res; 2008 Dec; 6(12):1795-806. PubMed ID: 19074825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis.
    Funk SD; Yurdagul A; Albert P; Traylor JG; Jin L; Chen J; Orr AW
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):686-95. PubMed ID: 22247258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size.
    Zapata-Mercado E; Biener G; McKenzie DM; Wimley WC; Pasquale EB; Raicu V; Hristova K
    J Biol Chem; 2022 Oct; 298(10):102370. PubMed ID: 35970390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration.
    Kaplan N; Fatima A; Peng H; Bryar PJ; Lavker RM; Getsios S
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):936-45. PubMed ID: 22247486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling.
    Leem AY; Shin MH; Douglas IS; Song JH; Chung KS; Kim EY; Jung JY; Kang YA; Chang J; Kim YS; Park MS
    Biochem Biophys Res Commun; 2017 Sep; 491(3):721-726. PubMed ID: 28743499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell adhesion and EGFR activation regulate EphA2 expression in cancer.
    Larsen AB; Stockhausen MT; Poulsen HS
    Cell Signal; 2010 Apr; 22(4):636-44. PubMed ID: 19948216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EphrinA1/EphA2 Promotes Epithelial Hyperpermeability Involving in Lipopolysaccharide-induced Intestinal Barrier Dysfunction.
    Chen Y; Zhang L; Zhang Y; Bai T; Song J; Qian W; Hou X
    J Neurogastroenterol Motil; 2020 Jul; 26(3):397-409. PubMed ID: 32606260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis.
    Taddei ML; Parri M; Angelucci A; Onnis B; Bianchini F; Giannoni E; Raugei G; Calorini L; Rucci N; Teti A; Bologna M; Chiarugi P
    Am J Pathol; 2009 Apr; 174(4):1492-503. PubMed ID: 19264906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.
    Wykosky J; Palma E; Gibo DM; Ringler S; Turner CP; Debinski W
    Oncogene; 2008 Dec; 27(58):7260-73. PubMed ID: 18794797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level.
    Mo J; Zhao X; Dong X; Liu T; Zhao N; Zhang D; Wang W; Zhang Y; Sun B
    Cell Oncol (Dordr); 2020 Aug; 43(4):655-667. PubMed ID: 32291572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy.
    Noblitt LW; Bangari DS; Shukla S; Mohammed S; Mittal SK
    Cancer Gene Ther; 2005 Jan; 12(1):46-53. PubMed ID: 15486559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.